NASH - Nonalcoholic Steatohepatitis Not Yet Recruiting Phase 4 Trials for Dulaglutide (DB09045)

IndicationStatusPhase
DBCOND0088313 (NASH - Nonalcoholic Steatohepatitis)Not Yet Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03648554Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)Treatment